Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth Reuters - 25 Apr 2024 Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth ... More
Regeneron signs Mammoth gene editing deal worth $100M upfront Fierce Biotech - 25 Apr 2024 Regeneron signs Mammoth gene editing deal worth $100M upfront ... More
Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration Genetic Engineering & Biotechnology News - 25 Apr 2024 Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration ... More
Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines MedCity News - 25 Apr 2024 Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines ... More
Regeneron falls after blockbuster drug misses revenue estimates XM - 25 Apr 2024 Regeneron falls after blockbuster drug misses revenue estimates ... More
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery BioSpace - 25 Apr 2024 Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery ... More
Regeneron & Mammoth Partner On CRISPR Therapies Contract Pharma - 25 Apr 2024 Regeneron & Mammoth Partner On CRISPR Therapies ... More
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study Yahoo - 25 Apr 2024 AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study ... More
Mammoth Bio inks Crispr-based collaboration with Regeneron The Pharma Letter - 25 Apr 2024 Mammoth Bio inks Crispr-based collaboration with Regeneron ... More
Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day MarketWatch - 24 Apr 2024 Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day ... More
Sales of Roche's juggernaut Vabysmo rout the analyst consensus Fierce Pharma - 24 Apr 2024 Sales of Roche's juggernaut Vabysmo rout the analyst consensus ... More
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study XM - 25 Apr 2024 AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study ... More
Regeneron Stock Under Microscope After DOJ Price Reporting Complaint—Key Levels to Watch Investopedia - 11 Apr 2024 Regeneron Stock Under Microscope After DOJ Price Reporting Complaint—Key Levels to Watch ... More
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key ... Yahoo Finance - 25 Apr 2024 Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key ... ... More
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond Fierce Biotech - 15 Apr 2024 Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond ... More
Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO Fierce Pharma - 25 Apr 2024 Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO ... More
Regeneron (REGN) Reports Next Week: What You Should Expect Yahoo - 25 Apr 2024 Regeneron (REGN) Reports Next Week: What You Should Expect ... More
US accuses Regeneron of fraudulent price reporting for eye drug Reuters - 10 Apr 2024 US accuses Regeneron of fraudulent price reporting for eye drug ... More
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks Yahoo - 24 Apr 2024 Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks ... More